Wikidata

(Q44073432)

English

Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations

scientific article

In more languages

Statements

title
Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12132671
retrieved
29 November 2017
author name string
Tomoko Kita
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12132671
retrieved
29 November 2017
Toshiyuki Sakaeda
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12132671
retrieved
29 November 2017
Nobuo Aoyama
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
12132671
retrieved
29 November 2017
Toshiyuki Sakai
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12132671
retrieved
29 November 2017
Yuko Kawahara
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
12132671
retrieved
29 November 2017
Masato Kasuga
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
12132671
retrieved
29 November 2017
Katsuhiko Okumura
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
12132671
retrieved
29 November 2017
publication date
1 July 2002
1 reference
stated in
Europe PubMed Central
PubMed ID
12132671
retrieved
29 November 2017
page(s)
923-927
1 reference
stated in
Europe PubMed Central
PubMed ID
12132671
retrieved
29 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44073432&oldid=2143330891"